InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Longer Than Most Free
01/23/17 1:37 PM
profile icon
Longer Than Most Free
01/23/17 1:23 PM
profile icon
FROZENFLAME Free
01/21/17 5:42 PM
profile icon
Longer Than Most Free
01/21/17 3:31 PM
profile icon
Longer Than Most Free
01/11/17 2:20 PM
profile icon
Longer Than Most Free
12/27/16 4:13 PM
profile icon
Longer Than Most Free
12/27/16 1:30 PM
profile icon
Longer Than Most Free
11/23/16 1:31 PM
profile icon
Longer Than Most Free
11/22/16 4:13 PM
profile icon
Longer Than Most Free
11/18/16 9:58 AM
profile icon
Longer Than Most Free
11/17/16 2:20 PM
profile icon
Mcgill Free
11/17/16 1:33 PM
profile icon
Longer Than Most Free
11/15/16 10:52 AM
profile icon
Longer Than Most Free
11/11/16 10:22 AM
profile icon
FROZENFLAME Free
11/10/16 4:34 PM
profile icon
Longer Than Most Free
11/10/16 4:09 PM
profile icon
Longer Than Most Free
11/09/16 10:37 AM
profile icon
Longer Than Most Free
11/07/16 4:11 PM
profile icon
Longer Than Most Free
11/03/16 12:49 PM
profile icon
FROZENFLAME Free
11/02/16 4:11 PM
profile icon
Longer Than Most Free
11/02/16 1:26 PM
profile icon
FROZENFLAME Free
10/31/16 9:59 AM
profile icon
Longer Than Most Free
10/28/16 6:27 PM
profile icon
FROZENFLAME Free
10/28/16 4:08 PM
profile icon
FROZENFLAME Free
10/27/16 5:39 PM
profile icon
Longer Than Most Free
10/27/16 2:09 PM
profile icon
FROZENFLAME Free
10/27/16 12:12 PM
profile icon
Longer Than Most Free
10/27/16 11:38 AM
profile icon
FROZENFLAME Free
10/27/16 11:37 AM
profile icon
Longer Than Most Free
10/27/16 10:50 AM
profile icon
Longer Than Most Free
10/26/16 4:49 PM
profile icon
FROZENFLAME Free
10/26/16 4:02 PM
profile icon
Longer Than Most Free
10/26/16 3:04 PM
profile icon
FROZENFLAME Free
10/26/16 12:07 PM
profile icon
FROZENFLAME Free
10/25/16 6:15 PM
profile icon
Longer Than Most Free
10/25/16 4:13 PM
profile icon
FROZENFLAME Free
10/25/16 4:02 PM
profile icon
FROZENFLAME Free
10/25/16 3:14 PM
profile icon
Longer Than Most Free
10/25/16 2:41 PM
profile icon
Longer Than Most Free
10/25/16 11:40 AM
profile icon
Longer Than Most Free
10/25/16 10:48 AM

EPIRUS Biopharm Inc (fka EPRSQ) RSS Feed

Followers
20
Posters
95
Posts (Today)
0
Posts (Total)
715
Created
04/15/15
Type
Free
Moderators
EPIRUS Biopharmaceuticals, Inc. 699 Boylston Street 8th Floor Boston, MA 02116 United States Phone: 617-600-4313 Website: http://www.epirusbiopharma.com EPIRUS Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops, manufactures, and commercializes biosimilar therapeutics worldwide. Its lead product candidate is BOW015, a biosimilar version of Remicade (infliximab) for the treatment of various inflammatory diseases. The company’s pipeline of biosimilar product candidates also include BOW050, a biosimilar version of Humira (adalimumab) to treat inflammatory diseases, including rheumatoid arthritis and various other forms of adult and pediatric arthritis, ankylosing spondylitis, inflammatory bowel disease, and chronic psoriasis and psoriasis; and BOW070, a biosimilar version of Actemra (tocilizumab) for the treatment of rheumatoid arthritis, polyarticular arthritis, and systemic juvenile idiopathic arthritis. It has a license agreement with Ranbaxy Laboratories Limited; license and collaboration agreement with Livzon Mabpharm Inc.; and license agreement with Bioceros B.V. The company is headquartered in Boston, Massachusetts.
Board Info
Posts Today
0
Posts (Total)
715
Posters
95
Moderators
New Post